Mark Connors

26.8k total citations · 6 hit papers
110 papers, 12.9k citations indexed

About

Mark Connors is a scholar working on Virology, Immunology and Epidemiology. According to data from OpenAlex, Mark Connors has authored 110 papers receiving a total of 12.9k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Virology, 77 papers in Immunology and 41 papers in Epidemiology. Recurrent topics in Mark Connors's work include HIV Research and Treatment (80 papers), Immune Cell Function and Interaction (68 papers) and T-cell and B-cell Immunology (36 papers). Mark Connors is often cited by papers focused on HIV Research and Treatment (80 papers), Immune Cell Function and Interaction (68 papers) and T-cell and B-cell Immunology (36 papers). Mark Connors collaborates with scholars based in United States, Canada and United Kingdom. Mark Connors's co-authors include Stephen A. Migueles, Richard A. Koup, Brian R. Murphy, W. Lesley Shupert, Daniel C. Douek, Claire W. Hallahan, Jason M. Brenchley, Michael R. Betts, Cai-Yen Firestone and Brenna J. Hill and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Mark Connors

108 papers receiving 12.6k citations

Hit Papers

HIV preferentially infect... 1999 2026 2008 2017 2002 2003 2002 2000 1999 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. HIV preferentially infects HIV-specific CD4+ T cells
    2002 982 citations Daniel C. Douek, Jason M. Brenchley et al. profile →
  2. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells
    2003 812 citations Jason M. Brenchley, Michael R. Betts et al. profile →
  3. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors
    2002 792 citations Stephen A. Migueles, Claire W. Hallahan et al. profile →
  4. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors
    2000 771 citations Stephen A. Migueles, Mark Connors et al. profile →
  5. HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression
    1999 629 citations Mark Connors, Richard A. Koup et al. profile →
  6. Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
    2012 619 citations Mark K. Louder, Nicole A. Doria‐Rose et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mark Connors 8.3k 8.1k 3.8k 3.6k 1.6k 110 12.9k
Scott Koenig 6.1k 0.7× 5.9k 0.7× 3.4k 0.9× 4.0k 1.1× 2.8k 1.7× 102 13.6k
Spyros A. Kalams 7.1k 0.9× 6.9k 0.9× 2.4k 0.6× 2.6k 0.7× 1.8k 1.1× 135 10.6k
Hanneke Schuitemaker 10.6k 1.3× 5.8k 0.7× 2.8k 0.7× 6.9k 1.9× 1.9k 1.2× 273 13.4k
M. Juliana McElrath 8.2k 1.0× 7.5k 0.9× 3.4k 0.9× 4.4k 1.2× 4.4k 2.7× 261 15.1k
Persephone Borrow 5.8k 0.7× 9.7k 1.2× 3.6k 1.0× 4.0k 1.1× 2.4k 1.5× 159 15.3k
Philip Goulder 10.7k 1.3× 10.9k 1.3× 3.3k 0.9× 4.9k 1.4× 2.9k 1.8× 208 16.8k
Christian Brander 7.6k 0.9× 7.7k 1.0× 2.9k 0.8× 3.4k 0.9× 3.2k 2.0× 242 13.5k
J. Steven McDougal 5.9k 0.7× 3.8k 0.5× 2.2k 0.6× 3.6k 1.0× 1.5k 0.9× 87 9.4k
Graham S. Ogg 5.3k 0.6× 15.1k 1.9× 5.0k 1.3× 3.5k 1.0× 2.4k 1.5× 291 22.7k
Britta Wahrén 4.4k 0.5× 4.5k 0.6× 5.4k 1.4× 3.3k 0.9× 3.1k 1.9× 491 13.7k

Countries citing papers authored by Mark Connors

Since Specialization
Citations

This map shows the geographic impact of Mark Connors's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Connors with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Connors more than expected).

Fields of papers citing papers by Mark Connors

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Connors. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Connors. The network helps show where Mark Connors may publish in the future.

Co-authorship network of co-authors of Mark Connors

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Connors. A scholar is included among the top collaborators of Mark Connors based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Connors. Mark Connors is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akahata, Wataru, Elizabeth Peters, Tae Min Kim, et al.. (2025). Incorporation of 5-methylcytidine alleviates RIG-I–mediated innate immune responses to a self-amplifying RNA vaccine. Science Translational Medicine. 17(824). eadz2276–eadz2276.
2.
Kwon, Young Do, Yile Li, Krisha McKee, et al.. (2021). Structures of HIV-1 Neutralizing Antibody 10E8 Delineate the Mechanistic Basis of Its Multi-Peak Behavior on Size-Exclusion Chromatography. Antibodies. 10(2). 23–23. 2 indexed citations
3.
Wagh, Kshitij, Michael S. Seaman, Dan H. Barouch, et al.. (2018). Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections. PLoS Pathogens. 14(3). e1006860–e1006860. 57 indexed citations
4.
Sheng, Zizhang, Chaim A. Schramm, Mark Connors, et al.. (2016). Effects of Darwinian Selection and Mutability on Rate of Broadly Neutralizing Antibody Evolution during HIV-1 Infection. PLoS Computational Biology. 12(5). e1004940–e1004940. 23 indexed citations
5.
Migueles, Stephen A., Nicole Frahm, Sushila A. Toulmin, et al.. (2014). HIV-Specific CD8+ T-cell Expansion Potential, but Not Cytotoxic Capacity, Is Associated with Reduced Set Point Viral Loads in Ad5/HIV Vaccinees. AIDS Research and Human Retroviruses. 30(S1). A175–A175. 1 indexed citations
6.
Kwon, Young Do, Ivelin S. Georgiev, Baoshan Zhang, et al.. (2014). Enhancing the Solubility of HIV-1-neutralizing Antibody 10E8. AIDS Research and Human Retroviruses. 30(S1). A150–A150. 3 indexed citations
7.
Mendoza, Daniel, Laura E. Ruff, David R. Ambrozak, et al.. (2012). HLA B*5701-Positive Long-Term Nonprogressors/Elite Controllers Are Not Distinguished from Progressors by the Clonal Composition of HIV-Specific CD8 + T Cells. Journal of Virology. 86(7). 4014–4018. 20 indexed citations
8.
Li, Yuxing, Sijy O’Dell, Richard F. Wilson, et al.. (2012). HIV-1 Neutralizing Antibodies Display Dual Recognition of the Primary and Coreceptor Binding Sites and Preferential Binding to Fully Cleaved Envelope Glycoproteins. Journal of Virology. 86(20). 11231–11241. 48 indexed citations
9.
Hersperger, Adam R., Stephen A. Migueles, Michael R. Betts, & Mark Connors. (2011). Qualitative features of the HIV-specific CD8+ T-cell response associated with immunologic control. Current Opinion in HIV and AIDS. 6(3). 169–173. 69 indexed citations
10.
Migueles, Stephen A., Julia E. Rood, Amy M. Berkley, et al.. (2011). Trivalent Adenovirus Type 5 HIV Recombinant Vaccine Primes for Modest Cytotoxic Capacity That Is Greatest in Humans with Protective HLA Class I Alleles. PLoS Pathogens. 7(2). e1002002–e1002002. 28 indexed citations
11.
Tilton, John C., Maura Manion, Marlise R. Luskin, et al.. (2008). Human Immunodeficiency Virus Viremia Induces Plasmacytoid Dendritic Cell Activation In Vivo and Diminished Alpha Interferon Production In Vitro. Journal of Virology. 82(8). 3997–4006. 70 indexed citations
12.
Pipeling, Matthew R., Erin E. West, Christine Osborne, et al.. (2008). Differential CMV-Specific CD8+ Effector T Cell Responses in the Lung Allograft Predominate over the Blood during Human Primary Infection. The Journal of Immunology. 181(1). 546–556. 32 indexed citations
13.
Kinter, Audrey, Jonathan P. McNally, Yin Lin, et al.. (2007). CD25 + Regulatory T Cells Isolated from HIV-Infected Individuals Suppress The Cytolytic And Nonlytic Antiviral Activity of HIV-specific CD8 + T Cells in Vitro. AIDS Research and Human Retroviruses. 23(3). 438–450. 111 indexed citations
14.
George, Thaddeus C., Ian Harmon, Erik Peterson, et al.. (2007). Measurement of nuclear translocation in primary cells using correlation analysis of images obtained on the ImageStream imaging flow cytometer (87.13). The Journal of Immunology. 178(1_Supplement). S130–S130. 1 indexed citations
15.
Price, David A., Jason M. Brenchley, Laura E. Ruff, et al.. (2005). Avidity for antigen shapes clonal dominance in CD8 + T cell populations specific for persistent DNA viruses. The Journal of Experimental Medicine. 202(10). 1349–1361. 300 indexed citations
16.
Betts, Michael R., David A. Price, Jason M. Brenchley, et al.. (2004). The Functional Profile of Primary Human Antiviral CD8+ T Cell Effector Activity Is Dictated by Cognate Peptide Concentration. The Journal of Immunology. 172(10). 6407–6417. 113 indexed citations
17.
Kawamura, Tatsuyoshi, Hiroyuki Gatanaga, Debra L. Borris, et al.. (2003). Decreased Stimulation of CD4+ T Cell Proliferation and IL-2 Production by Highly Enriched Populations of HIV-Infected Dendritic Cells. The Journal of Immunology. 170(8). 4260–4266. 59 indexed citations
18.
Gea‐Banacloche, Juan, JoAnn M. Mican, Claire W. Hallahan, et al.. (2000). Longitudinal Changes in CD4 + T Cell Antigen Receptor Diversity and Naive/Memory Cell Phenotype during 9 to 26 Months of Antiretroviral Therapy of HIV-Infected Patients. AIDS Research and Human Retroviruses. 16(17). 1877–1886. 21 indexed citations
19.
Connors, Mark, James E. Crowe, Cai-Yen Firestone, Brian R. Murphy, & Peter L. Collins. (1995). A Cold-Passaged, Attenuated Strain of Human Respiratory Syncytial Virus Contains Mutations in the F and L Genes. Virology. 208(2). 478–484. 44 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Scott Koenig Breakdown of academic impact, for papers by Spyros A. Kalams Breakdown of academic impact, for papers by Hanneke Schuitemaker Breakdown of academic impact, for papers by M. Juliana McElrath Breakdown of academic impact, for papers by Persephone Borrow Breakdown of academic impact, for papers by Philip Goulder Breakdown of academic impact, for papers by Christian Brander Breakdown of academic impact, for papers by J. Steven McDougal Breakdown of academic impact, for papers by Graham S. Ogg Breakdown of academic impact, for papers by Britta Wahrén
Rankless by CCL
2026